Together, these data demonstrate that modulating ATP synthase activity, whether by siRNA‐mediated knockdown of ATP5A or IF1 overexpression, phenocopies the neuroprotective effects of J147 in aging‐associated and AD‐like toxicities, and further support ATP5A as the molecular target for J147. Here, ATP5IF1 is linked to Alzheimer disease.